High-density lipoprotein cholesterol and angiographic coronary artery disease in black patients

American Heart Journal
|November 1, 1985
PubMed

Insights

Low high-density lipoprotein cholesterol (HDLC) may explain higher coronary artery disease (CAD) rates in Black women. Low-density lipoprotein cholesterol (LDLC) predicts CAD in men, while total cholesterol to HDLC ratio (TC:HDL) is key for women.

Area of Science:

  • Clinical Epidemiology
  • Cardiovascular Disease Research
  • Health Disparities

Background:

  • Clinical epidemiology of coronary artery disease (CAD) in Black patients is under-described.
  • Impact of major risk factors on CAD in this population requires further elucidation.

Purpose of the Study:

  • To investigate lipoprotein profiles and risk factors associated with CAD in Black patients.
  • To compare lipid profiles between Black patients with and without significant coronary artery narrowing.

Main Methods:

  • Lipoprotein profiles and risk factors measured in 114 Black patients undergoing cardiac catheterization.
  • Patients with significant coronary narrowing (≥50%) compared to those without.

Main Results:

  • Total cholesterol and low-density lipoprotein cholesterol (LDLC) associated with CAD in both sexes.
  • High-density lipoprotein cholesterol (HDLC) discriminatory value only in women.
  • Total cholesterol to HDLC ratio (TC:HDL) effective in both sexes, especially women, and in those over 55.
  • LDLC best predictor for men (LR=9.4); TC:HDL best for women (LR=15.7).

Conclusions:

  • LDLC is a key CAD predictor in Black men.
  • TC:HDL ratio is a significant CAD indicator in Black women.
  • Low HDLC may contribute to higher CAD incidence in Black women.
  • Further research on obesity and diabetes impact on HDLC in Black populations is warranted.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...